Recherche avancée

Gerard Florian is currently a Non-Executive Director at ANZ Bank New Zealand Ltd.
and a Group Executive-Technology & Group Services at Australia & New Zealand Banking Group Ltd.
and ANZ Group Holdings Ltd.
He previously worked as the Chief Marketing Officer at Dimension Data Australia Pty Ltd.
from 2003 to 2015.

John D.
Florian worked as the Chief Financial Officer-North America at Emerson Radio Corp..
Mr. Florian attended William Paterson University for his undergraduate degree.

Florian Schönharting is the founder of ACADIA Pharmaceuticals, Inc. (founded in 1993), Genmab A (founded in 1999), Nordic Biotech Advisors ApS (founded in 2001), Forward Pharma A (founded in 2005), and GH Research Plc (founded in 2018).
He holds the title of Chief Executive Officer at Nordic Biotech Advisors ApS and Chairman at Forward Pharma A and GH Research Plc.
Mr. Schönharting is also the founder of Zealand Pharma A and Life Cycle Pharma A.
Mr. Schönharting's current job(s) include Chairman at GH Research Ireland Ltd., Director at Danish Corporate Governance Association, and Manager at Tech Growth Invest ApS.
Mr. Schönharting's former job(s) include Director at Osteologix, Inc., Rose Pharma A, Osteologix Holdings Plc, Spree Pharma A, Blue Note Pharmaceuticals BV, and Aditech Pharma AB.
Mr. Schönharting's education history includes graduating from Copenhagen Business School.

Florian Fischer is the founder of MedVenture Partners GmbH, which was founded in 2002.
He held the position of Managing Director from 2002 to 2020.
Dr. Fischer also held former positions at AbCheck sro, Amphivena Therapeutics, Inc., Deutsche Bank AG, Affimed NV, KPMG LLP, Affimed NV Niederlassung Deutschland, Vivendy Therapeutics Ltd., and Vectura GmbH.
Dr. Fischer's education includes a doctorate from the University of Bielefeld and an undergraduate degree from Humboldt-Universität zu Berlin.